Statistics for A phase 4, single-arm, open-label, pilot study of maraviroc, raltegravir and darunavir/r in HIV-1 adults with triple class failure: TERCETO study
Total visits
| views | |
|---|---|
| A phase 4, single-arm, open-label, pilot study of maraviroc, raltegravir and darunavir/r in HIV-1 adults with triple class failure: TERCETO study | 1 |
Total visits per month
| views | |
|---|---|
| mayo 2024 | 1 |
| junio 2024 | 0 |
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
File Visits
| views | |
|---|---|
| 124_2012_Patterson_A phase 4, single-arm, open-label, pilot study of maraviroc, raltegravir and darunavir in HIV-1 adults with triple class failure TERCETO study.pdf | 5 |